tradingkey.logo

BUZZ-Cencora rises after lifting 2025 profit forecast

ReutersFeb 5, 2025 3:09 PM

Shares of drug distributor Cencora COR.N rise 1.7% to $255.77

Co raises fiscal 2025 profit forecast, driven by robust demand for expensive specialty medicines

Expects 2025 adj. profit to range between $15.25 and $15.55 per share, up from previous view of $15.15 to $15.45

Reports adj. Q1 profit of 3.73 per share, beating estimates of $3.50 per share - data compiled by LSEG

Q1 sales in its U.S. healthcare solutions segment rose 13.6% to $74.0 billion

"COR is off to a strong year stock-wise, but we see this quarter/guidance as another reason to see further upside on both estimates and multiple expansion," brokerage Leerink Partners says

Stock rose 9.4% in 2024

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI